Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
Information provided by:
Asociación para Evitar la Ceguera en México Identifier:
First received: June 30, 2006
Last updated: December 5, 2006
Last verified: November 2006
To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment

Condition Intervention Phase
Diabetic Retinopathy
Procedure: Vitrectomy
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Asociación para Evitar la Ceguera en México:

Primary Outcome Measures:
  • Surgical time
  • Facility of surgical maneuvers

Study Start Date: March 2006
Estimated Study Completion Date: June 2006

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Advanced diabetic retinopathy with retinal detachment

Exclusion Criteria:

  • Retinal detachments of more than 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00407108

Contact: Hugo Quiroz-Mercado, MD 5255 10841400 ext 1171

Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes" Recruiting
Mexico City, Mexico DF, Mexico, 04030
Contact: Maria A Martínez-Cstellanos, MD    52 55 10841400 ext 1171   
Principal Investigator: Hugo Quiroz-Mercado, MD         
Sub-Investigator: María A Martinez-Castellanos, MD         
Sub-Investigator: Gerardo García-Aguirre, MD         
Sub-Investigator: Orlando Ustariz-González, MD         
Sub-Investigator: Jose L Guerrero-Naranjo, MD         
Sub-Investigator: Jans Fromow-Guerra, MD         
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Principal Investigator: Hugo Quiroz-Mercado, MD Asociación para Evitar la Ceguera en México
  More Information Identifier: NCT00407108     History of Changes
Other Study ID Numbers: APEC-005
Study First Received: June 30, 2006
Last Updated: December 5, 2006

Keywords provided by Asociación para Evitar la Ceguera en México:
vitreoretinal surgery

Additional relevant MeSH terms:
Retinal Diseases
Diabetic Retinopathy
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases processed this record on May 25, 2017